1.035
Lexaria Bioscience Corp 주식(LEXX)의 최신 뉴스
Lexaria Bioscience Corp (NASDAQ: LEXX) Is Down -15.79% Since Its Low, And It’s Only Getting Started. - Stocksregister
Lexaria advances drug delivery tech with PharmaCO By Investing.com - Investing.com Nigeria
Raymond James Financial Inc. Makes New Investment in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World
Lexaria (LEXX) Advances Collaborative Pharmaceutical Research | - GuruFocus
Lexaria Advances Collaboration with Pharma Partner on Drug Delivery Technology - TipRanks
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company - marketscreener.com
Lexaria Provides Update on Material Transfer Agreement with Phar - GuruFocus
Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World
Lexaria Bioscience announces $2M registered direct offering; shares slip 19% - MSN
Lexaria Bioscience stock hits 52-week low at $1.14 By Investing.com - Investing.com India
Lexaria Bioscience stock hits 52-week low at $1.14 - Investing.com Australia
Lexaria Announces Closing of $2 Million Registered Direct Offeri - GuruFocus
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock - Yahoo Finance
Lexaria Bioscience Secures $2 Million in Direct Stock Offering - TipRanks
Lexaria Secures $2M Strategic Investment in Clean Direct Offering Amid Market Turbulence - Stock Titan
Market Watch Highlights: Lexaria Bioscience Corp (LEXX) Ends on an Downturn Note at 1.35 - DWinneX
Lexaria Bioscience Corp (LEXX) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
What is Zacks Small Cap’s Estimate for LEXX FY2025 Earnings? - Defense World
Lexaria Bioscience (LEXX) Announces $2M Direct Offering | LEXX S - GuruFocus
Lexaria Bioscience Secures $2 Million in Registered Direct Stock Offering - citybuzz -
Lexaria Announces $2 Million Registered Direct Offering of Commo - GuruFocus
Lexaria Bioscience secures $2 million in direct offering By Investing.com - Investing.com South Africa
Lexaria Bioscience secures $2 million in direct offering - Investing.com
Lexaria Announces $2 Million Registered Direct Offering of Common Stock - TradingView
Lexaria Lands $2M Strategic Investment: Institutional Investor Backs Biotech at $1.00 Per Share - Stock Titan
Lexaria Bioscience (OTCMKTS:LXRP) versus U.S. Gold (NASDAQ:USAU) Critical Comparison - Defense World
LEXX: Second Quarter Results - Yahoo Finance
Lexaria Bioscience (LEXX) Advances in GLP-1 Technology Amid Indu - GuruFocus
Recent GLP-1-Industry Developments Highlight the Promise of Lexa - GuruFocus
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology | LEXX Stock News - GuruFocus
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology - TradingView
Revolutionary Technology Could Solve GLP-1's Biggest Challenge: 64% Patient Dropout Rate - Stock Titan
Lexaria Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com
Lexaria Corp. Announces Oil Discovery at PPF-12-7 well in Belmont Lake - marketscreener.com
Lifezone Metals (NYSE:LZM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Review - Defense World
Lexaria Bioscience Corp reports results for the quarter ended February 28Earnings Summary - TradingView
Lexaria Bioscience Corp. SEC 10-Q Report - TradingView
60,640 Shares in Lexaria Bioscience Corp. (NASDAQ:LEXX) Acquired by Raymond James Financial Inc. - Defense World
Lexaria gets ethics board okay for oral GLP-1 study - MSN
We Think Lexaria Bioscience (NASDAQ:LEXX) Needs To Drive Business Growth Carefully - Yahoo
HighTower Advisors LLC Boosts Holdings in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World
Lexaria Completes Enrollment for Pioneering Drug Delivery Study - TipRanks
Lexaria completes enrollment for diabetes drug study - Investing.com
Lexaria completes enrollment for diabetes drug study By Investing.com - Investing.com UK
Lexaria's GLP-1 Study Hits Major Milestone with 20% Higher Patient Enrollment - Stock Titan
Lexaria begins human trial for oral diabetes treatment - Investing.com India
자본화:
|
볼륨(24시간):